Improving the Therapeutic Efficacy of Anti-Cancer Drugs through Nanotechnology
PDF

Keywords

Nanotechnology
Anti-cancer drugs
Drug delivery systems
Tumor targeting
Drug resistance
Liposomes

Abstract

Nanotechnology has emerged as a promising strategy to enhance the therapeutic efficacy of anti-cancer drugs. Traditional cancer treatments often face limitations such as poor bioavailability, toxicity, and resistance. Nanotechnology provides innovative solutions by utilizing nanoscale materials to improve the delivery, effectiveness, and targeting of anti-cancer drugs. This article explores the role of nanotechnology in improving drug bioavailability, targeting specific tumor sites, minimizing side effects, and overcoming resistance mechanisms. The application of nanocarriers, such as liposomes, dendrimers, and nanoparticles, offers new avenues in precision cancer therapy. Furthermore, it discusses the clinical challenges and future directions for integrating nanotechnology into cancer treatment.

PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2022 Dr. John Doe (Author)